Cover Image

Diagnostic value of CD56 and nm23 markers in papillary thyroid carcinoma

Context: Thyroid cancer is the most common malignant endocrine tumor. Nowadays tissue biopsy and pathological assessment are the best diagnostic modalities for thyroid lesions. Differential diagnosis between adenomas and follicular variant of papillary thyroid carcinoma (PTC) is an important issue i...

Full description

Saved in:

Bibliographic Details
Main Authors:	Karone Shahebrahimi (Author), Seyed H Madani (Author), Ali R Fazaeli (Author), Sedigheh Khazaei (Author), Malek Kanani (Author), Aliasghar Keshavarz (Author)
Format:	Book
Published:	Wolters Kluwer Medknow Publications, 2013-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The absence of CD56 expression can differentiate papillary thyroid carcinoma from other thyroid lesions
by: Ioana Golu, et al.
Published: (2017)

Application of CD56, P63 and CK19 immunohistochemistry in the diagnosis of papillary carcinoma of the thyroid
by: Alowami Salem, et al.
Published: (2008)

Frequency of Ki-67 (MIB-1) and P53 expressions among patients with prostate cancer
by: Seyed Hamid Madani, et al.
Published: (2011)

The Intraoperative Immunohistochemical Staining of CD56 and CK19 Improves Surgical Decision for Thyroid Follicular Lesions
by: Ju Yeon Pyo, et al.
Published: (2017)

The Usefulness of Immunocytochemistry of CD56 in Determining Malignancy from Indeterminate Thyroid Fine-Needle Aspiration Cytology
by: Hyunseo Cha, et al.
Published: (2018)

Evaluation of CD56dim and CD56bright natural killer cells in peripheral blood of women with IVF failures
by: Farahnaz Mardanian, et al.
Published: (2015)

Diagnostic Challenges of CD4+/CD56+/CD123+ hematological neoplasms
by: Leandro S. Thiago, et al.
Published: (2013)

Immunohistochemical Evaluation of β-catenin Marker in Papillary Thyroid Cancer Clinicopathologic Behavior
by: Katayoun Ziari, et al.
Published: (2018)

CD56 Expression in Odontogenic Cysts and Tumors
by: Zohreh Jaafari-Ashkavandi, et al.
Published: (2014)

Giant omental lipoblastoma and CD56 expression
by: Go Miyano, et al.
Published: (2013)

Mucins and NCAM (CD56) in intrahepatic cholangiocarcinogenesis
by: Anna Beatriz Telles Esperança, et al.
Published: (2014)

Notes and Queries, Number 56, November 23, 1850
by: Various

Metastatic papillary thyroid carcinoma to the nose: report and review of cutaneous metastases of papillary thyroid cancer
by: Philip R. Cohen
Published: (2015)

Juvenile-Onset Non-Poikilodermatous CD8+CD56+ Mycosis Fungoides
by: Thilo Gambichler, et al.
Published: (2024)

Noninvasive encapsulated papillary RAS-like thyroid tumor (NEPRAS) or encapsulated papillary thyroid carcinoma (PTC)
by: Pedro Weslley Rosario
Published: (2020)

Immunohistochemical markers of the activity of apoptosis and proliferation in women with adenomyosis who had papillary thyroid carcinoma
by: M.D. Tronko, et al.
Published: (2023)

Papillary variant of medullary carcinoma thyroid
by: Saumya Shukla, et al.
Published: (2014)

Thyroid Abscess as a Clinical Manifestation of Papillary Thyroid Carcinoma
by: Tri Juli Edi Tarigan, et al.
Published: (2022)

Warthin like papillary carcinoma - A rare variant of papillary carcinoma thyroid
by: Mir Wajahat, et al.
Published: (2018)

Markers of immune activation: novel biomarkers to predict the early-warning indicator of patients with papillary thyroid carcinoma
by: Hongsheng Lu, et al.
Published: (2020)

NM23-H1: a Metastasis-Associated Gene
by: Yi-Torng Tee, et al.
Published: (2006)

FOXP3 expression in papillary thyroid carcinoma with and without Hashimoto's thyroiditis
by: Murilo Pedreira Neves Junior, et al.
Published: (2013)

Cutaneous metastasis from papillary carcinoma of thyroid
by: Suyash S Tomar, et al.
Published: (2020)

Papillary carcinoma thyroid - A cytomorphological study
by: A Bhat, et al.
Published: (2016)

Papillary Thyroid Cancer Metastases to the Parathyroid Gland
by: Brian O'Sullivan, et al.
Published: (2022)

Anaplastic Transformation of Papillary Thyroid Cancer in the Retroperitoneum
by: James P. Solomon, et al.
Published: (2015)

Quantities of CD3+, CD8+ and CD56+ lymphocytes decline in breast cancer recurrences while CD4+ remain similar
by: Minna Mutka, et al.
Published: (2023)

Role of nm23H1 in predicting metastases in prostatic carcinoma
by: Arvind Kumar, et al.
Published: (2018)

CD3+, CD56+, CD4−, CD8−, CD20−, CD30− Peripheral T-Cell Non-Hodgkin's Lymphoma: A Rare Case Report
by: Ashish Jagati, et al.
Published: (2017)

Metastatic Papillary Thyroid Carcinoma with Multifocal Synchronous Transformation to Anaplastic Thyroid Carcinoma
by: Mark Benedict, et al.
Published: (2016)

Cytogenetics and FISH negative cryptic acute promyelocytic leukemia with CD56 expression
by: Jhansi Rani Arumugam, et al.
Published: (2021)

The clinical usefulness of chemokine C-X-C Motif Ligand 12 as a diagnostic marker for Papillary Thyroid Carcinoma
by: Sang Ah Lee, et al.
Published: (2020)

HISTOMORPHOMETRIC STUDY OF THE CELLULAR NUCLEUS OF THE THYROID PAPILLARY CARCINOMA
by: Raúl López Pérez, et al.
Published: (2013)

Expression of Estrogen and Progesterone Receptors in Papillary Thyroid Carcinoma
by: Mohammadreza Jalali-Nadoushan, et al.
Published: (2016)

Unusual Presentation of Papillary Microcarcinoma of Thyroid as Thigh Mass
by: Koyye Ravindranath Tagore, et al.
Published: (2011)

The diagnostic and prognostic value of vascularization in papillary thyroid microcarcinomas
by: I. V. Ivakhno
Published: (2015)

Papillary thyroid carcinoma variants with tall columnar cells
by: Chan Kwon Jung
Published: (2020)

Synchronous papillary thyroid carcinoma with mucinous rectal carcinoma
by: Barreto S, et al.
Published: (2009)

Papillary thyroid carcinoma with biomineralization: clinical and morphological features
by: R. A. Moskalenko, et al.
Published: (2016)

Expression of Caveolin-1 Is Associated With Thyroid Function in Patients With Human Papillary Thyroid Carcinoma
by: Jingyi Zhang, et al.
Published: (2020)